| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cell Biology |



* Division of Nephrology, University Health Network, University of Toronto, Toronto, Ontario, Canada;
Division of Epidemiology and Statistics, Ontario Cancer Institute, and University of Toronto, Toronto, Ontario, Canada;
Department of Laboratory Medicine and Pathology, University Health Network, University of Toronto, Toronto, Ontario, Canada; and
Experimental Therapeutics, Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada; || Department of Medicine, University of Toronto, Toronto, Ontario, Canada
Address correspondence to: Dr Heather Reich, University of Toronto, Medical Sciences Building, Clinical Science Division, Room 7326, 1 Kings College Circle, Toronto, ON M5S 1A8, Canada. Phone: 416-978-6870; Fax: 416-978-8765; h.reich{at}utoronto.ca
Received for publication March 23, 2004. Accepted for publication February 25, 2005.
Emerging clinical and experimental evidence strongly implicates proteinuria in the progression of kidney disease. One pathway involves the activation of NF
B by albumin, and it has been demonstrated that the activation of NF
B induced by albumin is dependent on mitogen-activated protein kinase ERK1/ERK2. To study the effect of albumin on gene expression, primary human renal tubular cells were exposed in vitro to albumin (1%) for 6 h, and gene expression profiling was performed with the human oligonucleotide microarray, U133A Affymetrix Gene Chip. In all, 223 genes were differentially regulated by albumin, including marked upregulation of the EGF receptor (EGFR) and IL-8. Accordingly, the authors sought to delineate the signaling pathway linking albumin to the EGFR and activation of ERK1/ERK2. It was found that albumin led to a dose- and time-dependent activation of ERK1/ERK2. Treatment with albumin led to EGFR phosphorylation, but the activation of ERK1/ERK2 was prevented by pretreatment of the cells with AG-1478, the EGFR kinase inhibitor, at a dose that inhibited EGF-induced ERK1/ERK2 activation. Exogenously administered reactive oxygen species (ROS) were found to activate ERK1/ERK2 via the EGFR and src tyrosine kinase activity and pretreatment of cells with the antioxidant N-acetylcysteine (NAC) and the NADPH oxidase inhibitor DPI abrogated albumin-induced activation of ERK1/ERK2. The src tyrosine kinase inhibitor, PP2, also inhibited the albumin-induced activation of ERK1/ERK2. Finally, pretreatment with AG-1478, the MEK inhibitor UO126, and NAC prevented the albumin-induced increase in IL-8 expression. The authors conclude that the EGF receptor plays a central role in the signaling pathway that links albumin to the activation of ERK1/ERK2 and increased expression of IL-8. Gene profiling studies suggest that there may be a positive feedback loop through the EGFR that amplifies the response of the proximal tubule cell to albumin. Taken together, these results suggest that the EGFR may be an important treatment target for kidney disease associated with proteinuria.
This article has been cited by other articles:
![]() |
M. M. van Timmeren, M.-L. Gross, W. Hanke, P. A. Klok, H. van Goor, C. A. Stegeman, and S. J. L. Bakker Oleic acid loading does not add to the nephrotoxic effect of albumin in an amphibian and chronic rat model of kidney injury Nephrol. Dial. Transplant., December 1, 2008; 23(12): 3814 - 3823. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. J. Lee and H. J. Han Albumin-stimulated DNA synthesis is mediated by Ca2+/PKC as well as EGF receptor-dependent p44/42 MAPK and NF-{kappa}B signal pathways in renal proximal tubule cells Am J Physiol Renal Physiol, March 1, 2008; 294(3): F534 - F541. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Arcidiacono, T. Sato, D. Alvarez-Hernandez, J. Yang, M. Tokumoto, I. Gonzalez-Suarez, Y. Lu, Y. Tominaga, J. Cannata-Andia, E. Slatopolsky, et al. EGFR Activation Increases Parathyroid Hyperplasia and Calcitriol Resistance in Kidney Disease J. Am. Soc. Nephrol., February 1, 2008; 19(2): 310 - 320. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. N. Reich, S. Troyanov, J. W. Scholey, D. C. Cattran, and for the Toronto Glomerulonephritis Registry Remission of Proteinuria Improves Prognosis in IgA Nephropathy J. Am. Soc. Nephrol., December 1, 2007; 18(12): 3177 - 3183. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Wong, G. Y. Oudit, H. Reich, Z. Kassiri, J. Zhou, Q. C. Liu, P. H. Backx, J. M. Penninger, A. M. Herzenberg, and J. W. Scholey Loss of Angiotensin-Converting Enzyme-2 (Ace2) Accelerates Diabetic Kidney Injury Am. J. Pathol., August 1, 2007; 171(2): 438 - 451. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Diwakar, A. L. Pearson, P. Colville-Nash, N. J. Brunskill, and M. E. C. Dockrell The role played by endocytosis in albumin-induced secretion of TGF-beta1 by proximal tubular epithelial cells Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1464 - F1470. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Chai and Z. Liu p38 Mitogen-Activated Protein Kinase Mediates Palmitate-Induced Apoptosis But Not Inhibitor of Nuclear Factor-{kappa}B Degradation in Human Coronary Artery Endothelial Cells Endocrinology, April 1, 2007; 148(4): 1622 - 1628. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Murali, A. W. Ackerman, A. J. Croatt, J. Cheng, J. P. Grande, S. L. Sutor, R. J. Bram, G. D. Bren, A. D. Badley, J. Alam, et al. Renal upregulation of HO-1 reduces albumin-driven MCP-1 production: implications for chronic kidney disease Am J Physiol Renal Physiol, February 1, 2007; 292(2): F837 - F844. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Hayden, N. A. Chowdhury, S. A. Cooper, A. Whaley-Connell, J. Habibi, L. Witte, C. Wiedmeyer, C. M. Manrique, G. Lastra, C. Ferrario, et al. Proximal tubule microvilli remodeling and albuminuria in the Ren2 transgenic rat Am J Physiol Renal Physiol, February 1, 2007; 292(2): F861 - F867. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Durkan, R. T. Alexander, G.-Y. Liu, M. Rui, G. Femia, and L. A. Robinson Expression and Targeting of CX3CL1 (Fractalkine) in Renal Tubular Epithelial Cells J. Am. Soc. Nephrol., January 1, 2007; 18(1): 74 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Okada, T. Inoue, T. Kikuta, Y. Watanabe, Y. Kanno, S. Ban, T. Sugaya, M. Horiuchi, and H. Suzuki A Possible Anti-Inflammatory Role of Angiotensin II Type 2 Receptor in Immune-Mediated Glomerulonephritis during Type 1 Receptor Blockade Am. J. Pathol., November 1, 2006; 169(5): 1577 - 1589. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C.W. Tang, J. C.K. Leung, L. Y.Y. Chan, A. W.L. Tsang, and K. N. Lai Activation of Tubular Epithelial Cells in Diabetic Nephropathy and the Role of the Peroxisome Proliferator-Activated Receptor-{gamma} Agonist J. Am. Soc. Nephrol., June 1, 2006; 17(6): 1633 - 1643. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673